News

Because unpleasant withdrawal symptoms fuel nicotine addiction's high relapse rate, targeting their underlying mechanisms ...
Vaping was also better across subanalyses by age, sex, nicotine dependence, and mental illness and resulted in fewer ...
More adults with social disadvantage receiving 8-week vaporized nicotine products vs. nicotine replacement therapy achieved 6 ...
A randomized controlled trial (RCT) evaluated whether vaporized nicotine products (VNPs) are more effective than nicotine ...
A study reveals a brain circuit between the interpeduncular nucleus and the laterodorsal tegmentum that drives nicotine ...
Nicotine vaping continues to outperform FDA-approved smoking cessation therapies in well-designed studies, including a new clinical trial conducted in Australia. This growing body of evidence badly ...
The HSE is not being given funding to tackle vaping or nicotine pouch addiction under current quit smoking programmes, it has ...
SKNY-1 was previously shown to achieve up to 30% weight loss, reverse nicotine craving, and preserve muscle mass in an animal model-and is designed to avoid the CNS side effects that halted earlier CB ...
Statement of Kathy Crosby, CEO and President, Truth Initiative WASHINGTON, July 11, 2025 /PRNewswire/ -- Arizona Attorney ...
Achieve Life Sciences has signed up Omnicom to support the launch of nicotine dependence treatment cytisinicline, positioning ...
Because unpleasant withdrawal symptoms fuel nicotine addiction's high relapse rate, targeting their underlying mechanisms with treatments may promote ...
Omnicom Group Inc. (NYSE:OMC) is one of the best high short interest stocks with huge upside potential. On June 26, Achieve ...